Join us for the University of Florida Brain Tumor Symposium on October 24, 2026, where leading experts will present the latest advances in the diagnosis and treatment of brain tumors. This comprehensive program will highlight emerging therapeutic strategies and explore key topics including gliomas, brain metastases, skull base tumors, pediatric tumors, and patient quality of life. Designed for multidisciplinary healthcare professionals, this symposium offers valuable insights to enhance clinical practice and improve patient outcomes in neuro-oncology.
Target Audience
Our target audience includes physicians and healthcare professionals involved in cancer care, including those specializing in hematology and oncology, radiation oncology, internal medicine, neurosurgery, pathology, immunology, and laboratory medicine.
This activity is designed for medical oncologists, radiation oncologists, pathologists, surgeons, and other physicians, as well as nurse practitioners, physician assistants, nurses, occupational therapists, students, social workers, and other healthcare professionals engaged in the multidisciplinary management of oncology patients.
Learning Objectives
At the conclusion of this activity, learners will be able to:
- Discuss current molecular pathology updates for patients.
- Identify emerging local and systemic molecularly treatment options for patients with gliomas.
- Discuss emerging role of cellular therapy in CNS tumors.
- Identify role of Radiation Oncology with precision medicine in CNS tumors.
- Discuss emerging role of viral therapy and focused ultrasound in CNS tumor.
- Identify standard and advancements in Radiation Oncology for Pediatric Neuro-Oncology.
- Discuss advancements of targeted therapy for CNS Metastases.
- Identify advancements in skull based tumor approaches.
- Describe the role of integrative and palliative medicine to improve quality of life for patients with CNS tumors.